Investment
Features
FeesSafety
Academy
More
Pluang+

Top dividend stocks like J&J, Coca-Cola, and P&G offer steady passive income amid market uncertainty.

Market News
15 Apr 2026
24/7 Wall Street
View Source
Bullish
pluang ai news

In uncertain markets with volatility and rising costs, dividend stocks provide reliable income regardless of employment status. Johnson & Johnson, Coca-Cola, and Procter & Gamble are highlighted for their strong dividend histories and financial health, collectively generating about $794 annually on a $30,000 investment. These blue-chip companies have decades of consecutive dividend increases, making them attractive for investors seeking stable, passive income that compounds over time. Their liquidity and automatic reinvestment options make them accessible compared to real estate or private credit investments.

More News (JNJ)

Johnson & Johnson beats Q2 earnings estimates and raises 2026 sales and EPS guidance.

Johnson & Johnson beats Q2 earnings estimates and raises 2026 sales and EPS guidance.

Johnson & Johnson reported better-than-expected Q2 2026 results with adjusted EPS of $2.90, surpassing estimates, and revenue of $25.31 billion, driven by strong pharmaceutical sales. Key growth came from the Innovative Medicine segment, with notable...

Company Fundamentals
Bullish
4 hours ago
FTSE 100 dips as miners fall on China slowdown; PayPal jumps on $53B bid from Stripe and Advent

FTSE 100 dips as miners fall on China slowdown; PayPal jumps on $53B bid from Stripe and Advent

The FTSE 100 dropped 23 points to 10,506, pressured by mining stocks reacting to China's slower-than-expected 4.3% GDP growth in Q2, its weakest in three years. European markets also declined, while US futures rose, led by tech. PayPal shares surged ...

Market News
Neutral
7 hours ago
Soft CPI eases Fed rate hike odds, PPI report today to confirm inflation trend and guide markets.

Soft CPI eases Fed rate hike odds, PPI report today to confirm inflation trend and guide markets.

US stock futures rose after a softer-than-expected Consumer Price Index (CPI) report reduced the chances of a Federal Reserve rate hike in July. The market now awaits today's Producer Price Index (PPI) data, which could either confirm easing inflatio...

Market News
Bullish
8 hours ago
DARZALEX sales hit $4.2B in Q2 2026, boosting Genmab royalties from J&J worldwide sales.

DARZALEX sales hit $4.2B in Q2 2026, boosting Genmab royalties from J&J worldwide sales.

Genmab announced that DARZALEX (daratumumab) achieved net trade sales of $4.207 billion globally in Q2 2026, with $2.435 billion from the U.S. and $1.772 billion from other regions. Genmab earns royalties on these worldwide sales through its licensin...

Company Fundamentals
Bullish
9 hours ago
Johnson & Johnson Q2 earnings expected to rise, stock hits record high amid strong outlook

Johnson & Johnson Q2 earnings expected to rise, stock hits record high amid strong outlook

Johnson & Johnson is set to report its Q2 2026 earnings with analysts expecting earnings per share of $2.85 and revenue of $25.02 billion, both higher than the previous year. The company has a strong track record of beating revenue estimates and its ...

Company Fundamentals
Bullish
19 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App